128 related articles for article (PubMed ID: 36330605)
1. Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram.
Liasis A; Paez-Escamilla M; Gruszewski J; Singh AD; Nischal KK
Ophthalmic Genet; 2023 Aug; 44(4):385-388. PubMed ID: 36330605
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
3. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
4. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
5. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
8. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
9. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
[TBL] [Abstract][Full Text] [Related]
11. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
Chao A; Kao LY; Liu L; Wang NK
BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
[TBL] [Abstract][Full Text] [Related]
12. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Suzuki S; Yamane T; Mohri M; Kaneko A
Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
[TBL] [Abstract][Full Text] [Related]
13. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
15. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
16. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
17. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
[TBL] [Abstract][Full Text] [Related]
18. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
20. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]